AHNS Virtual Education Series: Indications of PD-1 Inhibitors for Advanced cSCC
Date: Wednesday, April 14, 2021
Time: 4:00pm PT/5:00pm MT/6:00pm CT/7:00pm ET
This session is an hour long.
This session is complimentary to all attendees.
The webinar will review the current data supporting the approvals for immune checkpoint inhibitors. Cases will be utilized to highlight the direct clinical application.
Learning Objective:
At the conclusion of the activity, participants will be able to:
Define the current approved indications for immune checkpoint inhibitors.
Moderator:
Kevin Emerick, MD, Massachusetts Eye & Ear Infirmary
Panelists:
Gina Jefferson, MD, MS, The University of Mississippi Medical Center
Miriam Lango, MD, MD Anderson Cancer Center
David Miller, MD, PhD, Massachusetts General Cancer Center
